Ken Drazan, MD

Ken Drazan, MD is Chairman, CEO, and co-founder of ArsenalBio.  Immediately prior to Arsenal, Ken held the positions of President and Chief Business Officer of GRAIL (Acquired by ILMN). Prior to GRAIL,  Ken founded and was a Board Director of Verb Surgical (Acquired by JNJ).  Ken also co-founded private equity firm Bertram Capital with $2B+ AUM.  Ken is a Board-certified liver transplant surgeon with previous faculty appointments at Stanford and UCLA.